Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Spectrum Pharmaceuticals stock | 4.21

Own Spectrum Pharmaceuticals stock in just a few minutes.


Fact checked

Spectrum Pharmaceuticals, Inc is a biotechnology business based in the US. Spectrum Pharmaceuticals shares (SPPI) are listed on the NASDAQ and all prices are listed in US Dollars. Spectrum Pharmaceuticals employs 146 staff and has a trailing 12-month revenue of around USD$109.3 million.

How to buy shares in Spectrum Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Spectrum Pharmaceuticals. Find the stock by name or ticker symbol: SPPI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Spectrum Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$4.21, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Spectrum Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Spectrum Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Spectrum Pharmaceuticals's share price?

Since the stock market crash in March caused by coronavirus, Spectrum Pharmaceuticals's share price has had significant positive movement.

Its last market close was USD$4.21, which is 27.79% up on its pre-crash value of USD$3.04 and 141.65% up on the lowest point reached during the March crash when the shares fell as low as USD$1.7422.

If you had bought USD$1,000 worth of Spectrum Pharmaceuticals shares at the start of February 2020, those shares would have been worth USD$799.23 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,625.48.

Spectrum Pharmaceuticals share price

Use our graph to track the performance of SPPI stocks over time.

Spectrum Pharmaceuticals shares at a glance

Information last updated 2020-10-20.
Latest market close USD$4.21
52-week range USD$1.7422 - USD$10.57
50-day moving average USD$4.2154
200-day moving average USD$3.4537
Wall St. target price USD$11
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.548

Buy Spectrum Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Spectrum Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Spectrum Pharmaceuticals price performance over time

Historical closes compared with the close of $4.21 from 2020-11-16

1 week (2020-11-19) N/A
1 month (2020-10-30) 22.74%
3 months (2020-08-26) N/A
6 months (2020-05-26) N/A
1 year (2019-11-26) N/A
2 years (2018-11-26) N/A
3 years (2017-11-26) N/A
5 years (2015-11-26) N/A

Spectrum Pharmaceuticals financials

Revenue TTM USD$109.3 million
Gross profit TTM USD$0
Return on assets TTM -32.87%
Return on equity TTM -72.45%
Profit margin 0%
Book value $1.124
Market capitalisation USD$578.6 million

TTM: trailing 12 months

Shorting Spectrum Pharmaceuticals shares

There are currently 9.9 million Spectrum Pharmaceuticals shares held short by investors – that's known as Spectrum Pharmaceuticals's "short interest". This figure is 40% up from 7.1 million last month.

There are a few different ways that this level of interest in shorting Spectrum Pharmaceuticals shares can be evaluated.

Spectrum Pharmaceuticals's "short interest ratio" (SIR)

Spectrum Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Spectrum Pharmaceuticals shares currently shorted divided by the average quantity of Spectrum Pharmaceuticals shares traded daily (recently around 3.1 million). Spectrum Pharmaceuticals's SIR currently stands at 3.25. In other words for every 100,000 Spectrum Pharmaceuticals shares traded daily on the market, roughly 3250 shares are currently held short.

However Spectrum Pharmaceuticals's short interest can also be evaluated against the total number of Spectrum Pharmaceuticals shares, or, against the total number of tradable Spectrum Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Spectrum Pharmaceuticals's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Spectrum Pharmaceuticals shares in existence, roughly 70 shares are currently held short) or 0.0894% of the tradable shares (for every 100,000 tradable Spectrum Pharmaceuticals shares, roughly 89 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Spectrum Pharmaceuticals.

Find out more about how you can short Spectrum Pharmaceuticals stock.

Spectrum Pharmaceuticals share dividends

We're not expecting Spectrum Pharmaceuticals to pay a dividend over the next 12 months.

Have Spectrum Pharmaceuticals's shares ever split?

Spectrum Pharmaceuticals's shares were split on a 1:25 basis on 6 September 2002. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Spectrum Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Spectrum Pharmaceuticals shares which in turn could have impacted Spectrum Pharmaceuticals's share price.

Spectrum Pharmaceuticals share price volatility

Over the last 12 months, Spectrum Pharmaceuticals's shares have ranged in value from as little as $1.7422 up to $10.57. A popular way to gauge a stock's volatility is its "beta".

SPPI.US volatility(beta: 2.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spectrum Pharmaceuticals's is 2.214. This would suggest that Spectrum Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Spectrum Pharmaceuticals overview

Spectrum Pharmaceuticals, Inc., a biopharma company, develops and commercializes oncology and hematology drug products. The company is developing ROLONTIS, a novel long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNá, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of relapsed or refractory non-Hodgkin's lymphoma patients, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. for focused interferon therapeutics drug delivery platform. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site